Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Chubb
Johnson and Johnson
McKesson
Federal Trade Commission
Fish and Richardson
Dow
Deloitte
Argus Health
UBS

Generated: November 15, 2018

DrugPatentWatch Database Preview

Tentative Approvals for: Lek Pharm

« Back to Dashboard

Lek Pharm Drugs with Tentative Approvals

Applicant Generic Name NDA Strength Dosage Form
Lek Pharm acyclovir 074658 800MG TABLET;ORAL
Lek Pharm acyclovir 074750 200MG CAPSULE;ORAL
Lek Pharm acyclovir 074658 400MG TABLET;ORAL
Applicant Generic Name NDA Strength Dosage Form

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Chinese Patent Office
Healthtrust
Merck
Cantor Fitzgerald
McKesson
Colorcon
Deloitte
Express Scripts
Farmers Insurance

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.